Please use this identifier to cite or link to this item:
Title in Portuguese: Bioavailability of Different formulations of metformin hydrochloride in healthy volunteers : a comparative study
Author: Rodrigues Neto, Edilson Martins
Marques, Lídia Audrey Rocha Valadas
Cunha, Gilmara Holanda da
Pontes, Andrea Vieira
Lobo, Patrícia Leal Dantas
Nucci, Gilberto de
Moraes Filho, Manoel Odorico de
Moraes, Maria Elisabete Amaral de
Keywords: Metformina
Ensaio Clínico
Equivalência Terapêutica
Issue Date: Nov-2016
Publisher: International Archives of Medicine
Citation: RODRIGUES NETO, E. M. et al. Bioavailability of different formulations of metformin hydrochloride in healthy volunteers : a comparative study. International Archives of Medicine, v. 9, n. 300, p. 1-9, nov. 2016.
Abstract: Objective: To assess the bioavailability of a formulation of metformin hydrochloride 850 mg coated tablets as test, compared to a reference product with the same dosage form, in healthy volunteers of both genders. Method: This clinical trial was designed as randomised, comparative, single-dose, open-label, two-period, two-sequence, crossover study under fasting conditions. 28 healthy volunteers (fourteen men and fourteen women) took part in the study. The 850 mg coated tablets formulations were administered in a single dose orally. Blood samples were obtained prior to dosing and at 30 min, 1, 1:20; 1:40, 2, 2:20, 2:40; 3, 3:20, 3:40 4, 4:30, 5, 6, 8, 12, 16, 24 and 36 hours after drug administration with an one week washout period. Plasmatic concentrations of metformin were measured by specific and validated analytical methods based on high-performance liquid chromatography coupled to mass spectrometry (HPLC/MS). The pharmacokinetics parameter AUC0-36h, AUC0-∞ and Cmax were tested for bioequivalence after log transformation of data and ratios of Tmax were evaluated non parametrically. Findings: Data from this study showed that the test and the reference formulation presented similar results, within the acceptance range (80-125%) for AUC0-∞ (area under curve) and Cmax (maximum serum concentration of the drug) parameters, satisfying the bioequivalence criteria of the Brazilian Health Surveillance Agency and FDA. Conclusion: These results indicate that the two formulations of metformin hydrochloride 850 mg coated tablets are bioequivalent, thus, it will be possible to ensure interchangeability between them, which can generate market competition and better access to this treatment.
metadata.dc.type: Artigo de Periódico
ISSN: 1755-7682 On line
Appears in Collections:PPGF - Artigos publicados em revistas científica

Files in This Item:
File Description SizeFormat 
2016_art_emrodriguesneto.pdf150,26 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.